#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 19

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Idiopathic pulmonary fibrosis+1

Not recruiting

Investigational

Study on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:Bi 1839100

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Type 2 diabetes mellitus

Not recruiting

Registered drugNo placebo

Comparison of dapagliflozin versus metformin treatment in patients with early stage type 2 diabetes to evaluate survival and complications

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Dapagliflozin Propanediol

Contact Research Centre

Mantle cell lymphoma

Not recruiting

Registered drugNo placebo

Study of Acalabrutinib and Rituximab for Elderly Patients with Untreated Mantle Cell Lymphoma

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Liposarcoma

Not recruiting

Registered drugNo placebo

Study Comparing BI 907828 and Doxorubicin for Patients with Advanced Dedifferentiated Liposarcoma

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:(3S,3'S,3A's,10A's)-6-Chloro-3'-(3-Chloro-2-Fluorophenyl)-1'-(Cyclopropylmethyl)-6'-Methyl-2-Oxo-1,2,3',3A',10',10A'-Hexahydro-1'H-Spiro[Indole-3,2'-Pyrrolo[2',3':4,5]Pyrrolo[1,2-B]Indazole]-7'-Carboxylic Acid

Contact Research Centre

Polycythaemia vera+10

Not recruiting

Registered drugNo placebo

Study on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies

Registered drugNo placebo

Sweden

Participants:0–17 years · 18–64 years · 65+ years
Substances:Panobinostat

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on the Effects of Isatuximab with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Heart failure with preserved ejection fraction

Not recruiting

Registered drugNo placebo

Study of spironolactone and eplerenone in patients with heart failure with preserved ejection fraction (HFpEF)

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Altizide

Contact Research Centre

Liver operation

Not recruiting

Registered drug

Study on Lidocaine and Sodium Chloride for Patients Undergoing Liver Tumor Surgery

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Lidocaine

Contact Research Centre

Haematological malignancy+1

Not recruiting

Registered drugNo placebo

Study of GEN3014 and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma and Other Blood Cancers

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

EGFR gene mutation+1

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Bay 2927088

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.